Dramatic Health Taps Pharma Top Influencer Bob Cecere
Robert Cecere, a pharma sales leader and convergence media veteran, has joined Dramatic Health as Executive Vice President of Sales and Business Development. He brings over 20 years of executive leadership experience from industry giants including Remedy Health Media, HealthCentral, and Physicians Online. He most recently spent more than four years at Lifescript as Executive Vice President of Sales where he developed online advertising solutions that increased consumer awareness and drove demand for new prescriptions.
Cecere is a recognized thought leader throughout pharma, biotech, medical device companies, and their interactive agencies.
Publicis Health Promotes Alexandra von Plato CEO
Alexandra von Plato, having spent one year as Global Group President, has been appointed CEO of Publicis Health. Known as a digital marketing pioneer, she has overseen the creation of several award-winning, next-generation healthcare agencies, including Current Communications Company, Medical Broadcasting Company, and Digitas Health as well as directed disruptive brand marketing initiatives including the first unbranded pharma website and the first Rx-branded social campaign for industry leaders including Johnson & Johnson, Pfizer, and Weight Watchers.
“My goal is to make sure that we are building a portfolio of capabilities and services for the future of healthcare marketing, to ensure that suite of services and solutions is user ready, and help our clients take advantage of the evolving and changing healthcare marketing landscape,” von Plato says.
Ashfield
Ashfield, part of UDG Healthcare, appoints Amy Van Sant, PharmD, MBA as President of their new Medical Affairs business unit and Lee Ann Chaiken as Senior Vice President of the Pharmacovigilance business unit. Van Sant was most recently Director, Regulatory Advertising & Promotion for the Pharmaceutical Sector within the Johnson & Johnson Health Care Compliance & Privacy Organization, while Chaiken comes from her role as Senior Director, IT Implementation Services at IQVIA.
Axovant Sciences
Axovant has named Pavan Cheruvu, MD as CEO after having held leadership positions in parent company Roivant since 2015. A board-certified physician, Dr. Cheruvu completed his residency in internal medicine at Johns Hopkins Hospital. Prior to his medical training, he was a management consultant at McKinsey & Company, where he focused on biopharma strategy.
CMI/Compas
The healthcare media planning and buying company has promoted Elizabeth Barron and Justin Freid, both five-year employees with emerging media experience, to EVP, Managing Director roles. Barron was previously an account leader for major pharma brands, while Freid served as SVP, Search Engine Marketing and Emerging Media.
closerlook, inc.
The marketing and digital media agency appoints Steve Tulk to the role of Chief Technology Officer to guide investment in intelligence-driven technologies and marketing software product development. Prior to joining closerlook, Tulk was Chief Technology Officer for Kaptivating, LLC, Vice President of Information Technology at Siegfried, and Global Director and Chief Information Officer of Nike, Inc’s Hurley International subsidiary.
Envigo
Lynn Lewis, veteran of scientific pharmaceuticals and sales operations in the CRO industry, is now Senior Vice President, Global Sales. In her new role, she will strengthen the company’s position in the marketplace, using more than 20 years experience. Lewis spent 15 years at Covance where she was most recently Group VP of Business Development, Clinical Development, and Commercialization Services.
Guidemark Health
Guidemark has appointed healthcare communications veteran Michael Parisi as Chief Executive Officer, leading the agency’s Advertising/Marketing/Communications, Medical
Communications, and Learning businesses. Parisi is a 27-year healthcare communications veteran who most recently served as Managing Partner at Ogilvy CommonHealth Worldwide. He also sits on several nonprofit boards and currently serves as Board President for CancerCare.
Immunocore
Chief Commercial Officer since October 2017, Andrew Hotchkiss, will take over as interim CEO of Immunocore after Dr. Eliot Forster announced his resignation. Previously, Hotchkiss was Senior Vice President of Digital Ventures at Eli Lilly and Company, where he built a 20-year career.
imre
Jeff Smokler has been promoted to Partner at imre, where he has served as President for four of his six years at the agency. With more than 16 years of marketing communications experience, Smokler is prepared to play a large role in managing imre health. Prior to this, he was SVP at Weber Shandwick, where he led the agency’s public affairs efforts for CVS Health.
Oncoceutics Inc.
The oncology drug developer has appointed Minesh Mehta, MD, FASTRO, to the company’s Board of Directors. An expert in radiation oncology and clinical research in brain cancer, Dr. Mehta has held leadership positions within national cooperative groups such as NRG Oncology Radiation Therapy Oncology Group and the North American Brain Tumor Consortium.
Syneos Health
Syneos names Lisa van Capelle as Chief Human Resources Officer to deliver high-value, integrated clinical and commercial solutions to customers worldwide. She offers more than 20 years of HR expertise, especially in workforce management and cultural transformation capabilities providing scalable enterprise solutions. Prior to joining Syneos Health, Capelle was a senior strategic talent leader at Quintiles.
WCG
Shannon Bledsoe was named Executive Director at WCG, where she will be responsible for leading overall organizational growth and strategic direction, and overseeing the quality of WCG’s programming. She brings more than 20 years experience from various leadership positions at global nonprofits advocating for public health, and reproductive rights.
Wylei Inc.
The AI Predictive Content technology and marketing automation company has appointed Denice Torres to its Board of Directors. Torres has 25 years of digital marketing and consumer experience leadership expertise at Johnson & Johnson and Eli Lilly and Company. At J&J, she held presidential positions at McNeil Consumer Healthcare and Janssen Pharmaceuticals, CNS.
